Lynx1 Capital Management Lp Portfolio Stock Holdings

Lynx1 Capital Management Lp disclosed 23 stock positions valued at approximately $632.7 million in its latest SEC 13F filing. The largest holdings include STOKE THERAPEUTICS INC, CULLINAN THERAPEUTICS INC, and AGIOS PHARMACEUTICALS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 4, 2026.

Report Period
March 31, 2026
No. of Stocks
23
Portfolio Value
$632.7M
Holdings by Sector
Lynx1 Capital Management Lp Portfolio Holdings in Q1 2026

16 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
STOKE THERAPEUTICS INCSTOKHealthcare24.51%4,763,673-641,001-11.86%$155,105,193
CULLINAN THERAPEUTICS INCCGEMHealthcare20.13%8,963,500--$127,371,335
AGIOS PHARMACEUTICALS INCAGIOHealthcare13.96%2,611,568+2,531,944+3179.88%$88,349,345
DENALI THERAPEUTICS INCDNLIHealthcare5.71%1,880,303+141,553+8.14%$36,101,818
C4 THERAPEUTICS INCCCCCHealthcare2.91%6,998,902-99,231-1.40%$18,407,112
KORRO BIO INCKRROHealthcare2.75%1,538,296+860,381+126.92%$17,413,511
TSCAN THERAPEUTICS INCTCRXHealthcare1.28%8,019,148--$8,099,339
XENCOR INCXNCRHealthcare1.02%536,398-169,160-23.98%$6,468,960
PRECISION BIOSCIENCES INCDTILHealthcare0.86%985,113-8,800-0.89%$5,418,122
ENTRADA THERAPEUTICS INCTRDAHealthcare0.42%211,689+160,000+309.54%$2,671,515
CG ONCOLOGY INCCGONHealthcare0.34%31,591--$2,138,079
DESIGN THERAPEUTICS INCDSGNHealthcare0.20%119,516+50,000+71.93%$1,271,650
VYNE THERAPEUTICS INCVYNEHealthcare0.15%1,628,700+1,628,700+100.00%$973,148
WEREWOLF THERAPEUTICS INCHOWLHealthcare0.09%657,786+1,860+0.28%$547,673
IBIO INCIBIOHealthcare0.02%68,076+68,076+100.00%$129,344
ABSCI CORPORATIONABSIHealthcare0.01%21,245+21,245+100.00%$63,735